95.94 USD
↘ 6.25 (6.12%)LIVE (AS OF 12:54 PM EDT)
Mirum Pharmaceuticals, Inc. Common Stock
MIRMNASDAQ • USD
Market: OPEN
Open?$102.19
High?$107.11
Low?$95.66
Prev. Close?$102.19
Volume?376.2K
Avg. Volume?1.0M
VWAP?$98.11
Rel. Volume?0.37x
Bid / Ask
Bid?$82.54 × 100
Ask?$96.06 × 100
Spread?$13.52
Midpoint?$89.30
Valuation & Ratios
Market Cap?6.2B
Shares Out?61.0M
Float?48.8M
Float %?80.9%
P/E Ratio?N/A
P/B Ratio?25.70
EPS?-$13.10
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.
Employees
372
Market Cap
6.2B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2019-07-18
Address
989 EAST HILLSDALE BOULEVARD, SUITE 300
FOSTER CITY, CA 94404
Phone: 650-667-4085
FOSTER CITY, CA 94404
Phone: 650-667-4085
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.09Strong
Quick Ratio?1.99Adequate
Cash Ratio?1.19Strong
Debt/Equity?1.28Moderate
ValuationRICHLY VALUED
Score50/100
P/E?N/A▾
P/B?25.70HIGH▾
P/S?10.94HIGH▾
P/FCF?N/A▾
EV/EBITDA?-8.1CHEAP▾
EV/Sales?10.91HIGH▾
Returns & Efficiency
ROE?-329.4%WEAK▾
ROA?-89.7%WEAK▾
Cash Flow & Enterprise
FCF?$-172552000
Enterprise Value?$6.2B
Fundamentals ratios updated end of day